White Paper

Expanding The Viscosity Limits Of Peristaltic Dosing

By Harry Price, 3P innovation

3P - peristaltic pump

Modern injectable formulations, particularly in cell and gene therapy, are trending toward higher concentrations and viscosities that often exceed the operational limits of traditional peristaltic systems. Once fluids surpass 100 cP, elastic recovery in tubing degrades, leading to significant flow inconsistencies. While piston pumps offer a mechanical alternative, they sacrifice the single-use benefits critical for aseptic processing and introduce complex cleaning validation.

New performance data reveals that integrating closed-loop feedback and precision servo control allows peristaltic technology to maintain volumetric accuracy with fluids up to 2000 cP. Comparative studies demonstrate that this approach not only drastically improves accuracy against industry-standard units but also sustains performance over thousands of doses. Read the full analysis to see how peristaltic dosing is expanding into high-viscosity applications.

access the White Paper!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.

Subscribe to Pharmaceutical Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Pharmaceutical Online